Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: A SAR study
- 7 October 2008
- journal article
- Published by Springer Science and Business Media LLC in Investigational New Drugs
- Vol. 27 (4), 327-337
- https://doi.org/10.1007/s10637-008-9179-3
Abstract
To study the structure activity relationship (SAR) on the cytotoxic activity and probe the structural requirement for the potent antitumor activity, a series of novel diazaspiro bicyclo hydantoin derivatives were designed and synthesized. Their structures were confirmed by 1H NMR, LCMS and IR analyses. The antiproliferative effect of these compounds were determined against human leukemia, K562 (chronic myelogenous leukemia) and CEM (T-cell leukemia) cells using trypan blue and MTT assay, and the SAR associated with the position of N-terminal substituents in diazaspiro bicyclo hydantoin have also been discussed. It has been observed that these compounds displayed strong, moderate and weak cytotoxic activities. Interestingly, compounds having electron withdrawing groups at third and fourth position of the phenyl ring displayed selectively cytotoxic activities to both the cell lines tested with IC50 value lower than 50 μM. In addition, the cytotoxic activities of the compounds 7(a–o) bearing the substituents at N−3 position of diazaspiro bicyclo hydantoin increases in the order alkene > ester > ether and plays an important role in determining their antitumor activities. The position and number of substituents in benzyl group attached to N−8 of diazaspiro bicyclo hydantoin nucleus interacted selectively with specific targets leading to the difference of biochemical and pharmacological effects.Keywords
This publication has 21 references indexed in Scilit:
- Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship studyInvestigational New Drugs, 2008
- Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-dionesInvestigational New Drugs, 2008
- Fluorine in Pharmaceuticals: Looking Beyond IntuitionScience, 2007
- Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cellsInvestigational New Drugs, 2007
- Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small moleculesJournal of Fluorine Chemistry, 2006
- 5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activityBioorganic & Medicinal Chemistry Letters, 2006
- Fluorine in medicinal chemistry: A review of anti-cancer agentsJournal of Fluorine Chemistry, 2006
- Hydride-Promoted Ring Expansion of 2-Azaspiropyrrolinium Salts: An Approach Towards the Synthesis of (-)-NitramineSynlett, 2005
- De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffoldBioorganic & Medicinal Chemistry Letters, 2005
- Synthesis and Cytotoxic Evaluation of Novel Spirohydantoin Derivatives of the Dihydrothieno[2,3-b]naphtho-4,9-dione SystemJournal of Medicinal Chemistry, 2005